Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Chlamydia pneumoniae in atherosclerosis.

P Saikku1

  • 1KTL, National Public Health Institute, Department in Oulu, Oulu, Finland.

Journal of Internal Medicine
|April 13, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Periodontopathogen- and host-derived immune response in acute coronary syndrome.

Scandinavian journal of immunology·2011
Same author

The association of body mass index, waist and hip circumference, and waist-hip ratio with Chlamydia pneumoniae IgG antibodies and high-sensitive C-reactive protein at 31 years of age in Northern Finland Birth Cohort 1966.

International journal of obesity (2005)·2011
Same author

Interleukin-6-174 G/C promoter polymorphism is associated with persistence of Chlamydia pneumoniae antibodies in young men.

Scandinavian journal of immunology·2011
Same author

Elevated MMP-8 and decreased myeloperoxidase concentrations associate significantly with the risk for peripheral atherosclerosis disease and abdominal aortic aneurysm.

Scandinavian journal of immunology·2010
Same author

Chlamydia pneumoniae infection is associated with elevated body mass index in young men.

Epidemiology and infection·2009
Same author

Effects of CD14, TLR2, TLR4, LPB, and IL-6 gene polymorphisms on Chlamydia pneumoniae growth in human macrophages in vitro.

Scandinavian journal of immunology·2009

Chlamydia pneumoniae is a key infectious agent linked to atherosclerosis inflammation. Research confirms its presence in lesions and explores its pathogenic mechanisms in cardiovascular disease development.

Area of Science:

  • Infectious Diseases
  • Cardiovascular Pathology
  • Microbiology

Background:

  • Chlamydia pneumoniae is frequently implicated in the inflammation characteristic of atherosclerosis.
  • Numerous studies confirm a seroepidemiological link and the pathogen's presence within atherosclerotic lesions.
  • Technical challenges have historically limited comprehensive investigation into Chlamydia pneumoniae's role.

Purpose of the Study:

  • To investigate the potential pathogenic mechanisms by which Chlamydia pneumoniae infection contributes to atherosclerosis.
  • To supplement existing animal and intervention trial data with mechanistic insights.
  • To address the need for understanding how this infectious agent influences cardiovascular disease progression.

Main Methods:

  • Review of recent scientific literature suggesting pathogenic mechanisms.

Related Experiment Videos

  • Analysis of seroepidemiological data linking Chlamydia pneumoniae to atherosclerosis.
  • Examination of studies confirming the presence of Chlamydia pneumoniae in atherosclerotic lesions.

    • Main Results:

    • Evidence suggests Chlamydia pneumoniae plays a role in the inflammatory processes of atherosclerosis.
    • Multiple studies have confirmed the association between the infectious agent and arterial lesions.
    • Emerging research points to specific pathways through which C. pneumoniae may drive disease development.

    Conclusions:

    • Chlamydia pneumoniae is a significant factor associated with atherosclerotic inflammation.
    • Further research into pathogenic mechanisms is crucial for understanding its role in cardiovascular disease.
    • Understanding these mechanisms could inform future therapeutic strategies for atherosclerosis.